Fig. 3From: Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)Pain (including tingling) assessed by numeric rating scale score over 12 weeks of mirogabalin treatment: in the total (full analysis set) (A) and in subgroups with baseline NRS score ≥ 6 (B) or < 6 (C). Data are presented as mean ± SD [95% CI]. The p values, determined by paired t-test, are vs baseline. CI, confidence interval; LOCF, last observation carried forward; NRS, numeric rating scale; SD, standard deviationBack to article page